Pacific Biosciences of California: Piper Sandler raises target price to $3 from $2
PACB•Piper Sandler raised its target price for Pacific Biosciences of California to $3 from $2.
Related News
Mirum Pharmaceuticals CEO Christopher Peetz reports sale of $1.8 million in common shares
MIRM•
AllianceBernstein says insurers' liabilities should guide private credit allocations
AB•
E.L.F. Beauty target price raised to $110 from $100
ELF•
Biote Q3 revenue falls, misses analyst expectations on soft procedure segment
BTMD•
Sun Life Financial cut to Sector Perform from Outperform; target price cut to C$120 from C$124
SLF•